Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia
Condition(s):Central Nervous System Leukemia; Allogeneic Hematopoietic Stem Cell TransplantationLast Updated:December 28, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Central Nervous System Leukemia; Allogeneic Hematopoietic Stem Cell TransplantationLast Updated:December 28, 2022Not yet recruiting
Condition(s):Lymphoblastic LeukemiaLast Updated:December 23, 2022Not yet recruiting
Condition(s):Leukemia, Acute LymphoblasticLast Updated:January 11, 2024Terminated
Condition(s):Minimal Residual Disease; Leukemia, Lymphoblastic, Acute; Leukemia, Myelogenous, AcuteLast Updated:October 26, 2021Terminated
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:November 14, 2023Active, not recruiting
Condition(s):LeukemiaLast Updated:May 9, 2019Unknown status
Condition(s):Leukemia, Chronic Myeloid; Myeloid Leukemia, Chronic, Accelerated Phase; Myeloid Leukemia, Chronic, Chronic PhaseLast Updated:July 20, 2018Terminated
Condition(s):Acute Myeloid Leukemia; Essential ThrombocythemiaLast Updated:January 10, 2019Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:November 21, 2017Unknown status
Condition(s):LeukemiaLast Updated:May 18, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.